首页> 外文期刊>BMC Infectious Diseases >Use of monitoring indicators in hospital management of antimicrobials
【24h】

Use of monitoring indicators in hospital management of antimicrobials

机译:使用监测指标在医院管理抗菌药物中

获取原文
           

摘要

According to the literature, 25% to 50% of antimicrobials prescribed in hospitals are unnecessary or inappropriate, directly impacting antimicrobial resistance. Thus, the present study aimed to evaluate the use of antimicrobials in a university hospital in Northeast Brazil, using days of therapy (DOT) and length of therapy (LOT) indicators in accordance with the latest national and international recommendations for monitoring the use of antimicrobials. This is an observational, prospective analytical study conducted in a teaching hospital, with 94 active beds, distributed between the intensive care unit (ICU), the surgical clinic (SUR), the medical clinic (MED), the pneumology/infectology department (PNE/INF) and pediatrics (PED). The duration of the study was from the beginning of January to the end of December 2018. During the study period, a total of 11,634 patient-days were followed up and 50.4% of the patients were found to have received some antimicrobial, with a significant reduction in use of 1% per month throughout the year. Patients were receiving antimicrobial therapy for 376?days in every 1000?days of hospitalization (LOT?=?376/1000pd). Overall, the 1st-generation cephalosporins and fluoroquinolones were the most used in respect of the number of prescriptions and the duration of therapy. The calculated global DOT/LOT ratio showed that each patient received an average of 1.5 antimicrobials during the hospital stay. The incidence of antimicrobial resistance, globally, for both methicillin-resistant Staphylococcus aureus (methicillin R), Carbapenem-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii (Carbapenem R), was 1 per 1000 patient-days. The results obtained from the analyses revealed that half of the patients admitted to the hospital who took part in the study were exposed to the use of antimicrobials at some point during their stay. Although moderate, it is noteworthy that there was a decline in the use of antimicrobials throughout the year. The indicators used in this study were found to be very effective for gathering data on the use of antimicrobials, and assessing the results of the initiatives taken as part of the Stewardship program.
机译:根据文献,医院规定的25%至50%的抗菌药物是不必要的或不恰当的,直接影响抗微生物抗性。因此,本研究旨在评估在巴西东北巴西的大学医院中使用抗微生物的使用,并根据最新的国家和国际建议进行治疗使用抗菌药物的最新国家和国际建议。这是一个在教学医院进行的观察前瞻性分析研究,有94个活跃的床,分布在重症监护室(ICU)之间,手术诊所(SUR),医学诊所(MED),气敏/感染学部门(PNE) / INF)和儿科(PED)。该研究的持续时间是从1月初到2018年12月底。在研究期间,总共出现11,634例患者日,发现50.4%的患者接受了一些抗微生物,具有重要意义每年减少每月1%。患者在每1000次入院时间(批次?= 376 / 1000PD),患者接受抗菌治疗376?天数。总体而言,第一个生成的头孢菌素和氟代喹啉是对处方数量和治疗持续时间最受使用的。计算出的全局点/批次比率显示,每位患者在住院期间接受1.5个抗微生物的平均值。全球抗菌性抗性抗菌性耐药性,对于甲氧西林耐金黄色葡萄球菌(Methicililin R),CarbapeNem抗性Klebsiella Pneumoniae,假单胞菌铜绿假单胞菌和鲍曼(Carbapemem R),为每1000例患者。从分析中获得的结果表明,患有参与该研究的医院的一半患者接受了在逗留期间的某些时候使用抗微生物剂。虽然中度,值得注意的是,全年使用抗微生物的使用情况下降。发现本研究中使用的指标对于收集抗菌药物的数据非常有效,并评估作为管理计划的一部分所采取的举措的结果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号